The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
Multiple Sclerosis International Federation
3rd Floor Skyline House
200 Union Street
London, SE1 0LX
The Multiple Sclerosis International Federation (MSIF, formerly IFMSS) is an international non-profit federation of 42 national multiple sclerosis societies throughout the world. Multiple sclerosis (MS) is a progressive disease characterized by loss of myelin from nerve fibers within the brain and spinal cord (central nervous system). Myelin is a fatty substance that forms a protective, insulating sheath around certain nerve fibers, serving as an electrical insulator. The severity of MS may vary from case to case. Associated symptoms may include numbness, tingling, weakness, incoordination, visual abnormalities, and speech disturbances. Established in 1967, MSIF links the work of national MS societies worldwide. It is committed to working together and with the international research community to eliminate MS and its devastating effects. It also speaks out on a global level for those affected by MS. Its priorities are: stimulating global research; stimulating the active exchange of information; and providing support for the development of new and existing MS societies. The federation's ultimate goal is helping to eradicate multiple sclerosis. The federation also conducts international conferences, provides educational publications on various aspects of MS, and maintains a web site that offers understandable information on MS in several different languages.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions are strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.